BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 476333)

  • 41. [Treatment of severe Raynaud syndrome in scleroderma or thromboangiitis obliterans with prostacyclin (prostaglandin I2)].
    Rüthlein HJ; Riegger G; Auer IO
    Z Rheumatol; 1991; 50(1):16-20. PubMed ID: 2058317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders.
    Maricq HR; LeRoy EC; D'Angelo WA; Medsger TA; Rodnan GP; Sharp GC; Wolfe JF
    Arthritis Rheum; 1980 Feb; 23(2):183-9. PubMed ID: 7362667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EVALUATION OF LUMBAR SYMPATHETIC DENERVATION.
    KING RD; KAISER GC; LEMPKE RE; SHUMACKER HB
    Arch Surg; 1964 Jan; 88():36-47. PubMed ID: 14072535
    [No Abstract]   [Full Text] [Related]  

  • 44. [Digestive manifestations during systemic scleroderma].
    Gane S; Boicescu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(6):515-20. PubMed ID: 2577013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CRST syndrome and variant.
    Carr RD; Heisel EB
    Acta Derm Venereol; 1967; 47(5):345-9. PubMed ID: 4168793
    [No Abstract]   [Full Text] [Related]  

  • 46. [A case from practice (240). Progressive systemic sclerosis].
    Borer H; Kulstrunk M; Steiger U
    Schweiz Rundsch Med Prax; 1992 Apr; 81(15):489-91. PubMed ID: 1565941
    [No Abstract]   [Full Text] [Related]  

  • 47. [Griseofulvin administered for an indeterminate time in the therapy of systemic scleroderma and Raynaud's syndrome].
    Giordano M; Capelli L; Ara M; Tirri G
    Reumatismo; 1971; 23(2):82-92. PubMed ID: 5146109
    [No Abstract]   [Full Text] [Related]  

  • 48. Nicardipine for the treatment of Raynaud's phenomena: a double blind crossover trial of a new calcium entry blocker.
    Rupp PA; Mellinger S; Kohler J; Dorsey JK; Furst DE
    J Rheumatol; 1987 Aug; 14(4):745-50. PubMed ID: 3312603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes.
    LeRoy EC
    Curr Opin Rheumatol; 1992 Dec; 4(6):821-4. PubMed ID: 1457276
    [No Abstract]   [Full Text] [Related]  

  • 50. Raynaud syndrome.
    Blunt RJ; Porter JM
    Semin Arthritis Rheum; 1981 May; 10(4):282-308. PubMed ID: 6166048
    [No Abstract]   [Full Text] [Related]  

  • 51. [Subcutaneous calcifications. A case of Thibierge-Weissenbach syndrome].
    Tournay R
    Phlebologie; 1975; 28(4):565-8. PubMed ID: 1221440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon.
    Kallenberg CG; Wouda AA; The TH
    Am J Med; 1980 Nov; 69(5):675-80. PubMed ID: 6969028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low plasma protein nitrotyrosine levels distinguish primary Raynaud's phenomenon from scleroderma.
    Kingdon EJ; Mani AR; Frost MT; Denton CP; Powis SH; Black CM; Moore KP
    Ann Rheum Dis; 2006 Jul; 65(7):952-4. PubMed ID: 16308344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Antiendothelial antibodies in systemic scleroderma and Raynaud's disease].
    Salozhin KV; Shcherbakov AB; Nasonov EL; Kolesova NV; Romanov IuA; Guseva NG
    Ter Arkh; 1995; 67(5):54-7. PubMed ID: 7638782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Herzheiner's acrodermatitis chronica atrophicans. A clinical survey].
    Gip L; Molin L
    Nord Med; 1968 Jul; 80(28):901-4. PubMed ID: 5685657
    [No Abstract]   [Full Text] [Related]  

  • 56. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
    Wigley FM
    Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of correlation between gastric Helicobacter pylori infection and primary or secondary Raynaud's phenomenon in patients with systemic sclerosis.
    Sulli A; Seriolo B; Savarino V; Cutolo M
    J Rheumatol; 2000 Jul; 27(7):1820-1. PubMed ID: 10914880
    [No Abstract]   [Full Text] [Related]  

  • 58. [Raynaud's phenomena: diagnostic and treatment study].
    Priollet P
    Rev Prat; 1998 Oct; 48(15):1659-64. PubMed ID: 9814067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Laser Doppler skin perfusion pressure in the assessment of Raynaud's phenomenon.
    Kanetaka T; Komiyama T; Onozuka A; Miyata T; Shigematsu H
    Eur J Vasc Endovasc Surg; 2004 Apr; 27(4):414-6. PubMed ID: 15015193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Digital blood flow measurement by venous occlusion plethysmography in Raynaud's phenomenon. Value of the rewarming test].
    Cristol R; Debray J
    J Mal Vasc; 1986; 11(1):85-9. PubMed ID: 3944527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.